Biosensor structures for improved point of care testing and methods of manufacture thereof

US9487811B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9487811-B2
Application numberUS-201414206636-A
CountryUS
Kind codeB2
Filing dateMar 12, 2014
Priority dateMar 15, 2013
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to analytical testing devices and methods for fabricating electrochemical creatinine biosensors, and in particular using point of care electrochemical biosensors for testing for creatinine in samples. For example, the present invention may be directed to a biosensor having an electrode, a first printed layer formed on the electrode and having a first matrix that includes creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), and sarcosine oxidase (SOX), and second printed layer formed over the first printed layer and having a second matrix that includes CRH, SOX, and catalase.

First claim

Opening claim text (preview).

We claim: 1. A biosensor comprising: an electrode; a first printed layer formed on the electrode comprising a first matrix that includes creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), and sarcosine oxidase (SOX); a second printed layer formed over the first printed layer comprising a second matrix that includes CRH, SOX, and catalase; and a third printed layer formed over the first printed layer such that the third printed layer is disposed between the first printed layer and the second printed layer, the third printed layer comprising a third matrix that includes CRH, wherein the second printed layer completely covers the third printed layer; and wherein the third printed layer completely covers the first printed layer. 2. The biosensor of claim 1 , further comprising a fourth printed layer formed on the second printed layer comprising a fourth matrix that includes CRH, SOX, and catalase. 3. The biosensor of claim 1 , further comprising a silane layer formed on the electrode such that the silane layer is disposed between the electrode and the first printed layer. 4. The biosensor of claim 1 , further comprising a gamma amino silane layer formed on the electrode such that the gamma amino silane layer is disposed between the electrode and the first printed layer. 5. The biosensor of claim 1 , wherein a diameter of the electrode is less than a diameter of the first printed layer and a diameter of the second printed layer. 6. The biosensor of claim 1 , wherein the diameter of the first printed layer is less than or equal to the diameter of the second printed layer. 7. The biosensor of claim 1 , wherein the first matrix and the second matrix are polymer matrixes. 8. The biosensor of claim 1 , wherein the first matrix and the second matrix are selected from the group consisting of: polyvinyl alcohol, gelatin, acrylamide, polyethyleneglycol diacrylate, or combinations thereof. 9. The biosensor of claim 1 , wherein the first matrix and the second matrix are photoformable. 10. The biosensor of claim 1 , wherein the first matrix and the second matrix comprise a photoinitiator. 11. The biosensor of claim 10 , wherein the photoinitiator is stilbazonium or dichromate. 12. The biosensor of claim 1 , wherein the first printed layer and the second printed layer comprise a substantially concave shape. 13. The biosensor of claim 1 , wherein the first printed layer and the second printed layer comprise a substantially convex shape.

Assignees

Inventors

Classifications

  • C12Q1/005Primary

    involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence) · CPC title

  • After-treatment · CPC title

  • Sputtering · CPC title

  • Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood (amperometry per se G01N27/49; aspects concerning the enzyme reagent C12Q1/001) · CPC title

  • After-treatment of electroplated surfaces · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9487811B2 cover?
The present invention relates to analytical testing devices and methods for fabricating electrochemical creatinine biosensors, and in particular using point of care electrochemical biosensors for testing for creatinine in samples. For example, the present invention may be directed to a biosensor having an electrode, a first printed layer formed on the electrode and having a first matrix that in…
Who is the assignee on this patent?
Abbott Point Of Care Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).